Glycemic Control and the Risk of Death in 1,484 Patients Receiving Maintenance Hemodialysis

American Journal of Kidney Diseases

Volumn 55, Issue 5, 2010, Pages 875-884

  Shurraw, Sabin ^a   Majumdar, Sumit R ^a   Thadhani, Ravi ^b   Wiebe, Natasha ^a   Tonelli, Marcello ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

end stage renal disease; Glucose; hemodialysis; hemoglobin HbA1c; mortality

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MORTALITY;

AGED; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 77951621021     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.12.038     Document Type: Article

References (42)

1. Selvin E., Marinopoulos S., Berkenblit G., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141 6 (2004) 421-431
2. Yao Q., Pecoits-Filho R., Lindholm B., and Stenvinkel P. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol 38 5 (2004) 405-416
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 6 (2005) 1615-1625
4. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 14 (2006) 1681-1687
5. Wu M.S., Yu C.C., Yang C.W., et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol Dial Transplant 12 10 (1997) 2105-2110
6. Morioka T., Emoto M., Tabata T., et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24 5 (2001) 909-913
7. Oomichi T., Emoto M., Tabata T., et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study. Diabetes Care 29 7 (2006) 1496-1500
8. Hayashino Y., Fukuhara S., Akiba T., et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia 50 6 (2007) 1170-1177
9. Williams M.E., Lacson Jr. E., Teng M., Ofsthun N., and Lazarus J.M. Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival. Kidney Int 70 8 (2006) 1503-1509
10. Kalantar-Zadeh K., Kopple J.D., Regidor D.L., et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 30 5 (2007) 1049-1055
11. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis 45 suppl 3 (2005) 1-153
12. Levitan E.B., Song Y., Ford E.S., and Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?. A meta-analysis of prospective studies. Arch Intern Med 164 19 (2004) 2147-2155
13. Manns B., Owen Jr. W.F., Winkelmayer W.C., Devereaux P.J., and Tonelli M. Surrogate markers in clinical studies: problems solved or created?. Am J Kidney Dis 48 1 (2006) 159-166
14. Kalantar-Zadeh K., Kilpatrick R.D., McAllister C.J., Greenland S., and Kopple J.D. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th Annual Fall Conference and Scientific Sessions. Hypertension 45 4 (2005) 811-817
15. Fellstrom B.C., Jardine A.G., Schmieder R.E., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 14 (2009) 1395-1407
16. Wanner C., Krane V., Marz W., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 3 (2005) 238-248
17. Ikizler T.A. Resolved: being fat is good for dialysis patients: the Godzilla effect: pro. J Am Soc Nephrol 19 6 (2008) 1059-1062
18. Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next?. Semin Dial 18 5 (2005) 365-369
19. Davi G., Catalano I., Averna M., et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322 25 (1990) 1769-1774
20. Oswald G.A., Smith C.C., Delamothe A.P., Betteridge D.J., and Yudkin J.S. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 59 6 (1988) 663-671
21. Vague P., Raccah D., and Juhan-Vague I. Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysis. Metabolism 41 5 suppl 1 (1992) 2-6
22. Oliver M.F., and Opie L.H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343 8890 (1994) 155-158
23. Tansey M.J., and Opie L.H. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet 2 8347 (1983) 419-422
24. Drachman R.H., Root R.K., and Wood Jr. W.B. Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis. J Exp Med 124 2 (1966) 227-240
25. MacRury S.M., Gemmell C.G., Paterson K.R., and MacCuish A.C. Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 42 11 (1989) 1143-1147
26. McMahon M.M., and Bistrian B.R. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 9 1 (1995) 1-9
27. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 14 (1993) 977-986
28. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 9131 (1998) 837-853
29. Nathan D.M., Cleary P.A., Backlund J.Y., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 25 (2005) 2643-2653
30. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 24 (2008) 2545-2559
31. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 24 (2008) 2560-2572
32. Goodkin D.A., Young E.W., Kurokawa K., Prutz K.G., and Levin N.W. Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 44 5 suppl 2 (2004) 16-21
33. 1c measurements by various methods. Clin Chem Lab Med 38 4 (2000) 321-326
34. Kubota S., Ishikawa K., Kawasaki T., et al. Mechanism of hemoglobin A1 synthesis in renal failure. Tohoku J Exp Med 141 suppl (1983) 431-434
35. Eschbach Jr. J.W., Funk D., Adamson J., Kuhn I., Scribner B.H., and Finch C.A. Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276 12 (1967) 653-658
36. de Boer M.J., Miedema K., and Casparie A.F. Glycosylated haemoglobin in renal failure. Diabetologia 18 6 (1980) 437-440
37. Fisher J.W. Mechanism of the anemia of chronic renal failure. Nephron 25 3 (1980) 106-111
38. Eaton J.W., and Leida M.N. Hemolysis in chronic renal failure. Semin Nephrol 5 2 (1985) 133-139
39. Nakao T., Matsumoto H., Okada T., et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med 37 10 (1998) 826-830
40. De Marchi S., Cecchin E., Camurri C., et al. Origin of glycosylated hemoglobin A1 in chronic renal failure. Int J Artif Organs 6 2 (1983) 77-82
41. De Marchi S., Cecchin E., Basile A., et al. More on the increase of hemoglobin A1 in chronic renal failure: the role of acidosis. Nephron 35 1 (1983) 49-53
42. Fukuoka K., Nakao K., Morimoto H., et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology (Carlton) 13 4 (2008) 278-283